分子診断の世界市場：市場規模、市場シェア、動向分析、機会、予測：製品別、技術別、エンドユーザー別、用途別、地域別（2018年～2028年）

世界の分子診断の市場規模は、2021年の165億1,000万米ドルから2028年には394億米ドルに達し、予測期間（2022年～2028年）中に11.3%のCAGRで成長すると予測されています。 分子診断の技術的な開拓の進展、新興国での病気の早期診断に対する意識の高まりは、分子診断市場の成長を促進しています。

当レポートでは、世界の分子診断市場について調査しており、市場概要、市場分析、企業プロファイルなど、包括的な情報を提供しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界の分子診断市場の洞察

• 業界バリューチェーン分析
• DROC分析
  • 促進要因
    • 感染症とがんの有病率の増加
    • 検査コストの削減と調査活動の増加
    • 一般社会への認知度の向上
  • 抑制要因
    • 適切な請求ガイドラインの欠如による不利な払い戻し
    • その他
  • 機会
    • 新興国における成長機会
    • 遺伝子検査の需要の高まり
    • その他
  • 課題
    • 厳格な規制の枠組み
    • 代替技術のイントロダクション
• ポーターのファイブフォース分析
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の激しさ

第4章 世界の分子診断市場概要

• 市場規模と予測（2018年～2028年）：金額別
  • 金額別（10億米ドル）
• 市場シェアと予測
  • 製品別
    • 装置
    • 試薬
    • その他
  • 技術別
    • ポリメラーゼ連鎖反応（PCR）
    • ハイブリダイゼーション
    • DNAシーケンシング
    • マイクロアレイ
    • 等温核酸増幅技術（INAAT）
    • その他
  • エンドユーザー別
    • 診断検査室
    • 病院とクリニック
    • 研究機関
    • その他
  • 用途別
    • 感染症検査
    • 腫瘍検査
    • ファーマコゲノミクス
    • 遺伝子検査
    • 血液スクリーニング
    • 神経疾患
    • 循環器疾患検査
    • 微生物検査
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東およびアフリカ

第5章 北米の分子診断市場

• 市場規模と予測（2018年～2028年）：金額別
• 金額別（10億米ドル）
• 市場シェアと予測
  • 製品別
  • 技術別
  • エンドユーザー別
  • 用途別
  • 国別
    • 米国
    • カナダ

第6章 欧州の分子診断薬市場

• 市場規模と予測（2018年～2028年）：金額別
  • 金額別（10億米ドル）
• 市場シェアと予測
  • 製品別
  • 技術別
  • エンドユーザー別
  • 用途別
  • 国別
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • オランダ
    • ベルギー
    • 北欧諸国
    • その他欧州

第7章 アジア太平洋の分子診断市場

• 市場規模と予測（2018年～2028年）：金額別
  • 金額別（10億米ドル）
• 市場シェアと予測
  • 製品別
  • 技術別
  • エンドユーザー別
  • 用途別
  • 国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリアとニュージーランド
    • インドネシア
    • マレーシア
    • シンガポール
    • フィリピン
    • ベトナム
    • その他アジア太平洋

第8章 ラテンアメリカの分子診断市場

• 市場規模と予測（2018年～2028年）：金額別
  • 金額別（10億米ドル）
• 市場シェアと予測
  • 製品別
  • 技術別
  • エンドユーザー別
  • 用途別
  • 国別
    • ブラジル
    • メキシコ
    • アルゼンチン
    • ペルー
    • コロンビア
    • その他ラテンアメリカ

第9章 中東およびアフリカの分子診断市場

• 市場規模と予測（2018年～2028年）：金額別
  • 金額別（10億米ドル）
• 市場シェアと予測
  • 製品別
  • 技術別
  • エンドユーザー別
  • 用途別
  • 国別
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • クウェート
    • イラン
    • 南アフリカ
    • ナイジェリア
    • ケニア
    • エジプト
    • モロッコ
    • アルジェリア
    • その他中東

第10章 競合情勢

• 主要企業とその製品のリスト
• 企業の市場シェア分析（2021年）
• 競合ベンチマーキング：操作パラメータ別
• 主要な戦略的展開（合併、買収、パートナーシップなど）

第11章 COVID-19が世界の分子診断市場産業に与える影響

第12章 企業プロファイル（企業概要、財務マトリックス、競合情勢、主要な人員、主要な競合、連絡先住所、戦略的展望）

• ABOTT LABORATORIES
• Agilent Technologies Inc.
• BECTON DICKINSON AND COMPANY
• BIOMERIEUX SA
• HOFFMON LA-ROCHE LTD
• GRIFOLS S.A.
• HOLOGIC INC.
• QIAGEN INC
• SIEMENS AG
• その他

第13章 主要な戦略的推奨事項

第14章 調査手法

Global Molecular Diagnostics Market Flourishing at Robust 11.3% CAGR during Forecast Period

The global molecular diagnostics market is thriving because of rising technological developments in molecular diagnostics and a growing awareness of early disease diagnosis in emerging nations are driving market expansion.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global molecular diagnostics market at USD 16.51 billion in 2021. During the forecast period between 2022 and 2028, the size of global molecular diagnostics market is projected to grow at a CAGR of 11.3%, to reach a value of USD 39.4 billion by 2028. Global outbreaks of severe infectious diseases caused by pathogenic microorganisms have posed a huge threat to public health around the world, motivating researchers to create speedy and effective pathogen detection technologies. Traditionally, culture-based pathogen detection techniques have been considered gold standards. However, the significant turnaround time associated with these procedures, due to overnight culturing and pathogen isolation, limits their use. The invention and implementation of molecular diagnostic tools have ushered in a revolution in the diagnosis and surveillance of infectious diseases in recent years.

Global Molecular Diagnostics Market - Overview

Cellular-Molecular diagnostics is a broad term that refers to a group of diagnostic tests that examine a person's health on a cellular and molecular level, detecting and measuring specific cellular alterations, genetic sequences in deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), amino acids, and the proteins they express. The recent advancements in diagnostics such as PCR have gained popularity in recent years due to detection of infectious diseases and genetic modifications. This works by identifying the pathogenic DNA/RNA or abnormalities in cell culture. Molecular diagnostics work efficiently in producing highly accurate results. Furthermore, diagnostic companies have adopted advanced technologies like Artificial Intelligence to render products and services that could produce results in minimal duration with precision.

Impact of COVID-19 on Global Molecular Diagnostics Market

Coronavirus disease (COVID-19) is an extremely contagious illness. The COVID-19 virus causes mild to moderate respiratory disease in those who are infected. In December 2019, the COVID-19 strain was discovered in Wuhan, Hubei Province, China. It has since spread to various countries throughout the world, prompting the WHO to declare it a pandemic. COVID-19 molecular diagnostic testing has proven critical in the global response to the epidemic. Government organizations around the world are assisting laboratories in expediting COVID-19 testing methods since testing remains a critical step in preventing the disease's rapid spread. As a result, regulatory agencies used techniques to expedite the licensing of molecular diagnostic products.

Corporations have made strategic investments to adopt COVID-19 quick tests and reduce the impact of COVID-19 on their operating capabilities. Diagnostic testing continues to be the backbone of the COVID-19 response, enabling containment and mitigation activities. The severity of the crisis as well as the growing capacity issues associated with PCR-based testing pushed the development of diagnostic solutions to fulfill the demand for mass testing. COVID-19 testing and tracking procedures were built up by major players in the market. Various profiling methods, such as PCR testing panels and medicines, were approved by the FDA for emergency use in COVID-19 testing and diagnostics. Such advancements could drive global molecular diagnostics market.

Global Molecular Diagnostics Market - Regional Analysis

Developing economies, such as India, China, Brazil, Turkey, and South Africa could drive global molecular diagnostics market, as these countries' high disease prevalence, big patient population, expanding healthcare infrastructure, rising disposable income, and growing medical tourism. In addition to the above-mentioned characteristics, Asia Pacific has developed as a flexible and business-friendly center due to its tax regulatory and data requirements.

Competitive Landscape

The global market for molecular diagnostics is fiercely competitive with a number of prominent players. Mid-sized to small businesses, on the other hand, are expanding their market presence by releasing new devices at lower rates, all thanks to technical improvements and product innovations. Key companies in global molecular diagnostics market include Abbott Laboratories, F Hoffmann-la Roche Ltd, Hologic Corporation, Danaher Corporation, and Agilent Technology.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Molecular Diagnostics Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Molecular Diagnostics Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Type Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Molecular Diagnostics Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Increasing Prevalence of Infectious Diseases & Cancer
    • 3.2.1.2. Increasing Research Activities Set to Bring Down Cost of Testing and Boost Market Growth
    • 3.2.1.3. Increasing Awareness in General Public is a Great Opportunity for Market Expansion
  • 3.2.2. Restraints
    • 3.2.2.1. Unfavorable Reimbursement Due to Lack of Proper Billing Guidelines in Different Regions
    • 3.2.2.2. Others
  • 3.2.3. Opportunity
    • 3.2.3.1. Growth Opportunities in Emerging Economies
    • 3.2.3.2. Rising demand for genetic tests is a big opportunity for global molecular diagnostics market
    • 3.2.3.3. Others
  • 3.2.4. Challenges
    • 3.2.4.1. Strict Regulatory Framework
    • 3.2.4.2. Introduction of Alternative Technologies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Bargaining Power of Buyers
  • 3.3.3. Threat of New Entrants
  • 3.3.4. Threat of Substitutes
  • 3.3.5. Intensity of Rivalry

4. Global Molecular Diagnostics Market Overview

• 4.1. Market Size & Forecast by Value, 2018-2028
  • 4.1.1. By Value (USD Billion)
• 4.2. Market Share & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Instruments
    • 4.2.1.2. Reagents
    • 4.2.1.3. Others
  • 4.2.2. By Technology
    • 4.2.2.1. Polymerase Chain Reaction (PCR)
    • 4.2.2.2. Hybridization
    • 4.2.2.3. DNA Sequencing
    • 4.2.2.4. Microarray
    • 4.2.2.5. Isothermic Nucleic Acid Amplification Technology (INAAT)
    • 4.2.2.6. Others
  • 4.2.3. By End User
    • 4.2.3.1. Diagnostic Laboratories
    • 4.2.3.2. Hospitals & Clinics
    • 4.2.3.3. Research Institutions
    • 4.2.3.4. Others
  • 4.2.4. By Application
    • 4.2.4.1. Infectious Disease
    • 4.2.4.2. Oncology
    • 4.2.4.3. Pharmacogenomics
    • 4.2.4.4. Genetic Testing
    • 4.2.4.5. Blood Screening
    • 4.2.4.6. Neurological Disease
    • 4.2.4.7. Cardiovascular Disease
    • 4.2.4.8. Microbiology
    • 4.2.4.9. Others
  • 4.2.5. By Region
    • 4.2.5.1. North America
    • 4.2.5.2. Europe
    • 4.2.5.3. Asia Pacific
    • 4.2.5.4. Latin America
    • 4.2.5.5. Middle East and Africa

5. North America Molecular Diagnostics Market

• 5.1.1. Market Size & Forecast by Value, 2018-2028
• 5.1.2. By Value (USD Billion)
• 5.2. Market Share & Forecast
  • 5.2.1. By Product
  • 5.2.2. By Technology
  • 5.2.3. By End User
  • 5.2.4. By Application
  • 5.2.5. By Country
    • 5.2.5.1. United States
    • 5.2.5.1.1. By Product
    • 5.2.5.1.2. By Technology
    • 5.2.5.1.3. By End User
    • 5.2.5.1.4. By Application
    • 5.2.5.2. Canada
    • 5.2.5.2.1. By Product
    • 5.2.5.2.2. By Technology
    • 5.2.5.2.3. By End User
    • 5.2.5.2.4. By Application

6. Europe Molecular Diagnostics Market

• 6.1. Market Size & Forecast by Value, 2018-2028
  • 6.1.1. By Value (USD Billion)
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By End User
  • 6.2.4. By Application
  • 6.2.5. By Country
    • 6.2.5.1. Germany
    • 6.2.5.1.1. By Product
    • 6.2.5.1.2. By Technology
    • 6.2.5.1.3. By End User
    • 6.2.5.1.4. By Application
    • 6.2.5.2. United Kingdom
    • 6.2.5.2.1. By Product
    • 6.2.5.2.2. By Technology
    • 6.2.5.2.3. By End User
    • 6.2.5.2.4. By Application
    • 6.2.5.3. Italy
    • 6.2.5.3.1. By Product
    • 6.2.5.3.2. By Technology
    • 6.2.5.3.3. By End User
    • 6.2.5.3.4. By Application
    • 6.2.5.4. France
    • 6.2.5.4.1. By Product
    • 6.2.5.4.2. By Technology
    • 6.2.5.4.3. By End User
    • 6.2.5.4.4. By Application
    • 6.2.5.5. Spain
    • 6.2.5.5.1. By Product
    • 6.2.5.5.2. By Technology
    • 6.2.5.5.3. By End User
    • 6.2.5.5.4. By Application
    • 6.2.5.6. The Netherlands
    • 6.2.5.6.1. By Product
    • 6.2.5.6.2. By Technology
    • 6.2.5.6.3. By End User
    • 6.2.5.6.4. By Application
    • 6.2.5.7. Belgium
    • 6.2.5.7.1. By Product
    • 6.2.5.7.2. By Technology
    • 6.2.5.7.3. By End User
    • 6.2.5.7.4. By Application
    • 6.2.5.8. NORDIC Countries
    • 6.2.5.8.1. By Product
    • 6.2.5.8.2. By Technology
    • 6.2.5.8.3. By End User
    • 6.2.5.8.4. By Application
    • 6.2.5.9. Rest of Europe
    • 6.2.5.9.1. By Product
    • 6.2.5.9.2. By Technology
    • 6.2.5.9.3. By End User
    • 6.2.5.9.4. By Application

7. Asia Pacific Molecular Diagnostics Market

• 7.1. Market Size & Forecast by Value, 2018-2028
  • 7.1.1. By Value (USD Billion)
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By End User
  • 7.2.4. By Application
  • 7.2.5. By Country
    • 7.2.5.1. China
    • 7.2.5.1.1. By Product
    • 7.2.5.1.2. By Technology
    • 7.2.5.1.3. By End User
    • 7.2.5.1.4. By Application
    • 7.2.5.2. India
    • 7.2.5.2.1. By Product
    • 7.2.5.2.2. By Technology
    • 7.2.5.2.3. By End User
    • 7.2.5.2.4. By Application
    • 7.2.5.3. Japan
    • 7.2.5.3.1. By Product
    • 7.2.5.3.2. By Technology
    • 7.2.5.3.3. By End User
    • 7.2.5.3.4. By Application
    • 7.2.5.4. South Korea
    • 7.2.5.4.1. By Product
    • 7.2.5.4.2. By Technology
    • 7.2.5.4.3. By End User
    • 7.2.5.4.4. By Application
    • 7.2.5.5. Australia & New Zealand
    • 7.2.5.5.1. By Product
    • 7.2.5.5.2. By Technology
    • 7.2.5.5.3. By End User
    • 7.2.5.5.4. By Application
    • 7.2.5.6. Indonesia
    • 7.2.5.6.1. By Product
    • 7.2.5.6.2. By Technology
    • 7.2.5.6.3. By End User
    • 7.2.5.6.4. By Application
    • 7.2.5.7. Malaysia
    • 7.2.5.7.1. By Product
    • 7.2.5.7.2. By Technology
    • 7.2.5.7.3. By End User
    • 7.2.5.7.4. By Application
    • 7.2.5.8. Singapore
    • 7.2.5.8.1. By Product
    • 7.2.5.8.2. By Technology
    • 7.2.5.8.3. By End User
    • 7.2.5.8.4. By Application
    • 7.2.5.9. Philippines
    • 7.2.5.9.1. By Product
    • 7.2.5.9.2. By Technology
    • 7.2.5.9.3. By End User
    • 7.2.5.9.4. By Application
    • 7.2.5.10. Vietnam
    • 7.2.5.10.1. By Product
    • 7.2.5.10.2. By Technology
    • 7.2.5.10.3. By End User
    • 7.2.5.10.4. By Application
    • 7.2.5.11. Rest of Asia Pacific
    • 7.2.5.11.1. By Product
    • 7.2.5.11.2. By Technology
    • 7.2.5.11.3. By End User
    • 7.2.5.11.4. By Application

8. Latin America Molecular Diagnostics Market

• 8.1. Market Size & Forecast by Value, 2018-2028
  • 8.1.1. By Value (USD Billion)
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By End User
  • 8.2.4. By Application
  • 8.2.5. By Country
    • 8.2.5.1. Brazil
    • 8.2.5.1.1. By Product
    • 8.2.5.1.2. By Technology
    • 8.2.5.1.3. By End User
    • 8.2.5.1.4. By Application
    • 8.2.5.2. Mexico
    • 8.2.5.2.1. By Product
    • 8.2.5.2.2. By Technology
    • 8.2.5.2.3. By End User
    • 8.2.5.2.4. By Application
    • 8.2.5.3. Argentina
    • 8.2.5.3.1. By Product
    • 8.2.5.3.2. By Technology
    • 8.2.5.3.3. By End User
    • 8.2.5.3.4. By Application
    • 8.2.5.4. Peru
    • 8.2.5.4.1. By Product
    • 8.2.5.4.2. By Technology
    • 8.2.5.4.3. By End User
    • 8.2.5.4.4. By Application
    • 8.2.5.5. Colombia
    • 8.2.5.5.1. By Product
    • 8.2.5.5.2. By Technology
    • 8.2.5.5.3. By End User
    • 8.2.5.5.4. By Application
    • 8.2.5.6. Rest of Latin America
    • 8.2.5.6.1. By Product
    • 8.2.5.6.2. By Technology
    • 8.2.5.6.3. By End User
    • 8.2.5.6.4. By Application

9. Middle East & Africa Molecular Diagnostics Market

• 9.1. Market Size & Forecast by Value, 2018-2028
  • 9.1.1. By Value (USD Billion)
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By End User
  • 9.2.4. By Application
  • 9.2.5. By Country
    • 9.2.5.1. Saudi Arabia
    • 9.2.5.1.1. By Product
    • 9.2.5.1.2. By Technology
    • 9.2.5.1.3. By End User
    • 9.2.5.1.4. By Application
    • 9.2.5.2. UAE
    • 9.2.5.2.1. By Product
    • 9.2.5.2.2. By Technology
    • 9.2.5.2.3. By End User
    • 9.2.5.2.4. By Application
    • 9.2.5.3. Qatar
    • 9.2.5.3.1. By Product
    • 9.2.5.3.2. By Technology
    • 9.2.5.3.3. By End User
    • 9.2.5.3.4. By Application
    • 9.2.5.4. Kuwait
    • 9.2.5.4.1. By Product
    • 9.2.5.4.2. By Technology
    • 9.2.5.4.3. By End User
    • 9.2.5.4.4. By Application
    • 9.2.5.5. Iran
    • 9.2.5.5.1. By Product
    • 9.2.5.5.2. By Technology
    • 9.2.5.5.3. By End User
    • 9.2.5.5.4. By Application
    • 9.2.5.6. South Africa
    • 9.2.5.6.1. By Product
    • 9.2.5.6.2. By Technology
    • 9.2.5.6.3. By End User
    • 9.2.5.6.4. By Application
    • 9.2.5.7. Nigeria
    • 9.2.5.7.1. By Product
    • 9.2.5.7.2. By Technology
    • 9.2.5.7.3. By End User
    • 9.2.5.7.4. By Application
    • 9.2.5.8. Kenya
    • 9.2.5.8.1. By Product
    • 9.2.5.8.2. By Technology
    • 9.2.5.8.3. By End User
    • 9.2.5.8.4. By Application
    • 9.2.5.9. Egypt
    • 9.2.5.9.1. By Product
    • 9.2.5.9.2. By Technology
    • 9.2.5.9.3. By End User
    • 9.2.5.9.4. By Application
    • 9.2.5.10. Morocco
    • 9.2.5.10.1. By Product
    • 9.2.5.10.2. By Technology
    • 9.2.5.10.3. By End User
    • 9.2.5.10.4. By Application
    • 9.2.5.11. Algeria
    • 9.2.5.11.1. By Product
    • 9.2.5.11.2. By Technology
    • 9.2.5.11.3. By End User
    • 9.2.5.11.4. By Application
    • 9.2.5.12. Rest of Middle East & Africa
    • 9.2.5.12.1. By Product
    • 9.2.5.12.2. By Technology
    • 9.2.5.12.3. By End User
    • 9.2.5.12.4. By Application

10. Competitive Landscape

• 10.1. List of Key Players and Their Offerings
• 10.2. Company Market Share Analysis, 2021
• 10.3. Competitive Benchmarking, By Operating Parameters
• 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, and others)

11. Impact of Covid-19 on Global Molecular Diagnostics Market Industry

12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)

• 12.1. ABOTT LABORATORIES
• 12.2. Agilent Technologies Inc.
• 12.3. BECTON DICKINSON AND COMPANY
• 12.4. BIOMERIEUX SA
• 12.5. HOFFMON LA-ROCHE LTD
• 12.6. GRIFOLS S.A.
• 12.7. HOLOGIC INC.
• 12.8. QIAGEN INC
• 12.9. SIEMENS AG
• 12.10. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

• 14.1. Qualitative Research
  • 14.1.1. Primary & Secondary Research
• 14.2. Quantitative Research
• 14.3. Market Breakdown & Data Triangulation
  • 14.3.1. Secondary Research
  • 14.3.2. Primary Research
• 14.4. Breakdown of Primary Research Respondents, By Region
• 14.5. Assumptions & Limitations